FDA is cautioning healthcare professionals and patients that proton pump inhibitors (PPIs) may increase the risk of fractures of the hip, wrist and spine. The drugs’ labeling will be revised to reflect these concerns. PPIs are used to reduce gastric…
Food and Drug Adminstration (FDA): Patient Safety News